PT76045B - Process for preparing imidazo <4,5-c> quinoline - Google Patents

Process for preparing imidazo <4,5-c> quinoline

Info

Publication number
PT76045B
PT76045B PT7604582A PT7604582A PT76045B PT 76045 B PT76045 B PT 76045B PT 7604582 A PT7604582 A PT 7604582A PT 7604582 A PT7604582 A PT 7604582A PT 76045 B PT76045 B PT 76045B
Authority
PT
Portugal
Prior art keywords
quinoline
preparing imidazo
imidazo
preparing
Prior art date
Application number
PT7604582A
Other languages
Portuguese (pt)
Other versions
PT76045A (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of PT76045A publication Critical patent/PT76045A/en
Publication of PT76045B publication Critical patent/PT76045B/en

Links

PT7604582A 1981-12-30 1982-12-29 Process for preparing imidazo <4,5-c> quinoline PT76045B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33594481A 1981-12-30 1981-12-30

Publications (2)

Publication Number Publication Date
PT76045A PT76045A (en) 1983-01-01
PT76045B true PT76045B (en) 1985-12-13

Family

ID=23313895

Family Applications (1)

Application Number Title Priority Date Filing Date
PT7604582A PT76045B (en) 1981-12-30 1982-12-29 Process for preparing imidazo <4,5-c> quinoline

Country Status (4)

Country Link
GR (1) GR78412B (en)
IL (1) IL67566A0 (en)
IT (1) IT8249761A0 (en)
PT (1) PT76045B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7902214B2 (en) 2004-12-17 2011-03-08 3M Innovative Properties Company Method of treating a mucosal and/or dermal associated condition

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL73534A (en) * 1983-11-18 1990-12-23 Riker Laboratories Inc 1h-imidazo(4,5-c)quinoline-4-amines,their preparation and pharmaceutical compositions containing certain such compounds
US8889154B2 (en) 2005-09-15 2014-11-18 Medicis Pharmaceutical Corporation Packaging for 1-(2-methylpropyl)-1H-imidazo[4,5-c] quinolin-4-amine-containing formulation

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7902214B2 (en) 2004-12-17 2011-03-08 3M Innovative Properties Company Method of treating a mucosal and/or dermal associated condition
US7902216B2 (en) 2004-12-17 2011-03-08 3M Innovative Properties Company Pharmaceutical creams with refined oleic acid
US7902211B2 (en) 2004-12-17 2011-03-08 3M Innovative Properties Company Method of inducing interferon biosynthesis
US7902243B2 (en) 2004-12-17 2011-03-08 3M Innovative Properties Company Methods for improving imiquimod availability at two months, four months and six months between refined and compendial
US7902242B2 (en) 2004-12-17 2011-03-08 3M Innovative Properties Company Method of stabilizing imiquimod
US7902245B2 (en) 2004-12-17 2011-03-08 3M Innovative Properties Company Methods for reducing imiquimod impurities for two months, four months, and six months
US7902209B2 (en) 2004-12-17 2011-03-08 3M Innovative Proerties Company Method of preparing a pharmaceutical cream and minimizing imiquimod impurity formation
US7902212B2 (en) 2004-12-17 2011-03-08 3M Innovative Properties Company Reduction of imiquimod impurities at six months using refined oleic acid
US7902210B2 (en) 2004-12-17 2011-03-08 3M Innovative Properties Company Reduction of IMIQUIMOD impurities at two months using refined oleic acid
US7902213B2 (en) 2004-12-17 2011-03-08 3M Innovative Properties Company Pharmaceutical cream with reduced imiquimod impurities at four months using refined oleic acid
US7902244B2 (en) 2004-12-17 2011-03-08 3M Innovative Properties Company Method of preparing a pharmaceutical cream and minimizing imiquimod impurity formation (at least four months storage)
US7902215B2 (en) 2004-12-17 2011-03-08 3M Innovative Properties Company Pharmaceutical creams with reduced imiquimod impurities
US7902246B2 (en) 2004-12-17 2011-03-08 3M Innovative Properties Company Methods for controlling formation of imiquimod impurities for two months, four months, and six months
US7906525B2 (en) 2004-12-17 2011-03-15 3M Innovative Properties Company Reduction of imiquimod impurities at four months using refined oleic acid
US7906526B2 (en) 2004-12-17 2011-03-15 3M Innovative Properties Company Method of treating a dermal and/or mucosal associated condition
US7906524B2 (en) 2004-12-17 2011-03-15 3M Innovative Properties Company Pharmaceutical cream having similar or less levels of imiquimod impurity formation as cream with BHA (comparator)
US7906543B2 (en) 2004-12-17 2011-03-15 3M Innovative Properties Company Method of reducing imiquimod impurity formation
US7906527B2 (en) 2004-12-17 2011-03-15 3M Innovative Properties Company Reduction of imiquimod impurities using refined oleic acid
US7915277B2 (en) 2004-12-17 2011-03-29 3M Innovative Properties Company Method of treating genital or peri-anal warts
US7915279B2 (en) 2004-12-17 2011-03-29 3M Innovative Properties Company Method of treating mollescum contagiosum
US7915278B2 (en) 2004-12-17 2011-03-29 3M Innovative Properties Company Method of treating basal cell carcinoma
US7919501B2 (en) 2004-12-17 2011-04-05 3M Innovative Properties Company Method of controlling formation of imiquimod impurities
US7923463B2 (en) 2004-12-17 2011-04-12 3M Innovative Properties Company Methods for stabilizing imiquimod for two months, four months, and six months
US7928118B2 (en) 2004-12-17 2011-04-19 3M Innovative Properties Company Reduction of imiquimod impurities in pharmaceutical creams
US7928117B2 (en) 2004-12-17 2011-04-19 3M Innovative Properties Company Method of inducing cytokine biosynthesis
US7928116B2 (en) 2004-12-17 2011-04-19 3M Innovative Properties Company Method of treating actinic keratosis
US7939555B2 (en) 2004-12-17 2011-05-10 3M Innovative Properties Company Method of preparing a pharmaceutical cream and minimizing imiquimod impurity formation
US8080560B2 (en) 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
US8557838B2 (en) 2004-12-17 2013-10-15 Medicis Pharmaceutical Corporation Immune response modifier formulations containing oleic acid and methods

Also Published As

Publication number Publication date
IT8249761A0 (en) 1982-12-28
IL67566A0 (en) 1983-05-15
PT76045A (en) 1983-01-01
GR78412B (en) 1984-09-27

Similar Documents

Publication Publication Date Title
PT72370B (en) Process for preparing imidazo&lt;1,2-a&gt;piridines
PT75115B (en) Process for preparing novel imidazo &lt;1,2-a&gt; pyridines and pyra-zines
PT74504A (en) Process for preparing imidazodiazepines
PT76607A (en) Process for preparing 2-phenylimidazo &lt;4,5-c&gt; piridine
DE3268413D1 (en) Process for preparing chlorotrifluoromethylbenzene
DE3261535D1 (en) Process for preparing aryldiazosulphonates
PT75680B (en) Process for preparing 5-phenyl-2s-pentanol
DE3261580D1 (en) Process for preparing 4-haloazetidin-2-ones
PL237052A1 (en) Process for preparing novel imidazo-/1,2-a/-pyrimidines
PL236742A1 (en) Process for preparing novel 1,4,9,10-tetrahydropyrazolo-/4,3-/pyrido/3,2-b//1,4/diazopin-10-ones
DE3263114D1 (en) Process for the preparation of 5,6,7,7a-tetrahydro-4h-thieno (3,2-c) pyridin-2-one derivatives
PT76045B (en) Process for preparing imidazo &lt;4,5-c&gt; quinoline
PT79987A (en) Process for preparing 2-arylimidazo&lt;4,5-c&gt;pyridines
PT71177A (en) Process for preparing 3-substituted imidazo (1,2-a) piridines
YU202182A (en) Process for preparing pyrido (1,2,3-de)(1,4)-benzoxazine-6-carboxylic acid
HUT34477A (en) Process for preparing pyrido/1,4/-benzodiazepines
YU43724B (en) Process for preparing 5,11-dihydro-6h-pyrido/2,3-b/ /1,4/-benzodiazepin-6-ones
DE3267381D1 (en) Process for preparing beta-chloroalanine
DE3262826D1 (en) Process for preparing m-alkylhydroxybenzene
GB2112777B (en) Process for preparing mononitrochlorobenzene
DE3260363D1 (en) Process for preparing 3-alkylaminophenols
HU182165B (en) Process for preparing 5-oxo-hexahydro-indolo/2&#39;,3&#39;:3,4/ /pyrido/2,1-b/quinazolines
YU135482A (en) Process for preparing new substituted 2-methylene-1h-2,3,56-tetrahydro-imidazo(1,2-a)imidazoles
PL239428A1 (en) Process for preparing pyrbuterol
YU172081A (en) Process for preparing 8-ethyl-5-oxy-2-piperazinyl-5,8-dihydro-pyrido(2,3-d)-6-pyrimidine-carboxylic acid